Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2026 · third_quarter · Q3
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Filing targets: Food & Drug Administration (FDA)
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2026 · second_quarter · Q2
Source: Senate LDA
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
No Handouts for Drug Advertisements Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
End Prescription Drug Ads Now Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
DTC Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Responsibility in Drug Advertising Act of 2025
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Children and Teens’ Online Privacy Protection Act
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
S.836 - Children and Teens Online Privacy Protection Act
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
American Privacy Rights Act of 2024
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.8818 - American Privacy Rights Act of 2024 (APRA)
American Privacy Rights Act of 2024
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
American Privacy Rights Act of 2024
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.8818 - American Privacy Rights Act of 2024 APRA)
American Privacy Rights Act of 2024
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.
Client: COALITION FOR HEALTHCARE COMMUNICATIONS · Firm: COALITION FOR HEALTHCARE COMMUNICATIONS
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Filing targets: SENATE
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2026 · first_quarter · Q1
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2025 · fourth_quarter · Q4
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Filing targets: SENATE
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2025 · third_quarter · Q3
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Filing targets: SENATE
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2025 · second_quarter · Q2
S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now
Filing targets: SENATE
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2025 · first_quarter · Q1
S.836 - Children and Teens Online Privacy Protection Act
Filing targets: SENATE
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2024 · fourth_quarter · Q4
H.R.8818 - American Privacy Rights Act of 2024 (APRA)
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2024 · third_quarter · Q3
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals. H.R.8818 - American Privacy Rights Act of 2024 (APRA) to provide Americans with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement.
H.R.8818 - American Privacy Rights Act of 2024 APRA)
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2024 · second_quarter · Q2
U.S. Department of Labor's Overtime and Independent Contractor Rule
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL)
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2024 · first_quarter · Q1
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
Filing targets: HOUSE OF REPRESENTATIVES
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2023 · fourth_quarter · 4A
H.R.4402 - To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes, specifying that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
Filing targets: HOUSE OF REPRESENTATIVES
COALITION FOR HEALTHCARE COMMUNICATIONS via COALITION FOR HEALTHCARE COMMUNICATIONS
2023 · fourth_quarter · RR
Advertising: Advocacy for First Amendment right for media and advertising professional organizations. Tax: maintaining the treatment of advertising as a full deductible ordinary and necessary business expense. Health Data Privacy Sunshine Act: Clarify that medial textbooks and clinical articles should be deemed non-reportable under the patient education exclusion.
Advertising: Advocacy for First Amendment right for media and advertising professional organizations. Tax: maintaining the treatment of advertising as a full deductible ordinary and necessary business expense. Health Data Privacy Sunshine Act: Clarify that medial textbooks and clinical articles should be deemed non-reportable under the patient education exclusion.
Tax Cuts and Jobs Act of 2017 (TCJA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax Cuts and Jobs Act of 2017 (TCJA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advertising: Advocacy for First Amendment right for media and advertising professional organizations. Tax: maintaining the treatment of advertising as a full deductible ordinary and necessary business expense. Health Data Privacy Sunshine Act: Clarify that medial textbooks and clinical articles should be deemed non-reportable under the patient education exclusion.